AULT yields 930.67% · ABBV yields 3.06%● Live data
📍 AULT pulled ahead of the other in Year 1
Combined, AULT + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AULT + ABBV for your $10,000?
Ault Alliance, Inc., through its subsidiaries, provides customized solutions for the military markets in North America, Europe, the Middle East, and internationally. The company operates through eight segments: Energy and Infrastructure, Technology and Finance, SMC, BNI, GIGA, TurnOnGreen, AGREE, and Ault Disruptive. It offers lifting services; virtual markets, real world goods marketplaces, gaming, sweepstakes gaming, contest of skill, and building private spaces, as well as social hubs and unique and virtual world. The company also provides consumer electronic solutions; commercial loans, convertible notes, and revolving lines of credit; and virtual training courses through the LightSpeedVT platform, as well as creates various media, communications, and content, including web development, corporate communications, social media, and scripted and unscripted television. In addition, it invests in public and private companies; and various commercial and residential real estate, including hospitality, multifamily, and industrial properties, as well as operates hotels and other commercial real estate, and data centers; and Bitcoin mining activities. It sells its products directly through its sales force, as well as through manufacturer representatives and distributors. It serves crane services, oil exploration, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles industries. The company was formerly known as BitNile Holdings, Inc. and changed its name to Ault Alliance, Inc. in January 2023. Ault Alliance, Inc. was incorporated in 1969 and is headquartered in Las Vegas, Nevada.
Full AULT Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.